Jay Shepard insider trades
Open-market stock purchases and sales by Jay Shepard, Director at Esperion Therapeutics, Inc, from SEC Form 4 filings since Sep 26, 2013.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | — |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $28.8K |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $73.1K |
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc | Sold (not open market) | $38.3K |
| Jun 16, 2026 | IRWD Ironwood Pharmaceuticals Inc | Bought (not open market) | — |
| May 28, 2026 | ESPR Esperion Therapeutics, Inc | Bought (not open market) | — |
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- ESPR Esperion Therapeutics, Inc: other filings, last Jul 13, 2026
- IRWD Ironwood Pharmaceuticals Inc: other filings, last Jun 16, 2026
- INO Inovio Pharmaceuticals, Inc: other filings, last May 20, 2026
- ARAV Aravive, Inc: 7 sales, last Apr 8, 2020
- VSAR Versartis, Inc: 14 sales, last May 22, 2018
- MRNS Marinus Pharmaceuticals Inc: other filings, last Jan 17, 2017
- DRRX Durect Corp: other filings, last Jun 22, 2016